Comparison of Drug Persistence and Incidence of Tuberculosis Between Tumor Necrosis Factor-alpha Inhibitors and Tocilizumab as the First-line Biological Treatment in Patients with Rheumatoid Arthritis Using the Korean Health Insurance Review and Assessment Service Database